BMI Revises Pharmaceutical Market Data

BMI View: Argentina's ARS29.14bn (US$7.45bn) pharmaceutical market is a good proposition for multinational pharmaceutical companies. Projected growth is robust: the five-year compound annual growth rate (CAGR) is11.9% in US dollar terms; per-capita spending is one of the highest in Latin America (US$183 in 2010); and the regulatory regime is one of the fastest in the world. However, downside risks must not be underestimated. Shortcomings in the intellectual property protection and the country's uncertain exchange rate policy represent the most significant risks.

To read the full article, please choose one of the following options: